SBC
insider transactionsSBC Medical Group Holdings Inc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-8.0M
0 buy · 8.0M sell
Net value · 365d
-$20.2M
$0 in · $20.2M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
3
0 buy · 8.0M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Yoshiyuki Aikawa KEY
Chairman and CEO
$1.4M
465.0K sh · $3.02
Own -1%
-
Sell·S
Yoshiyuki Aikawa KEY
Chairman and CEO
$9.4M
3.1M sh · $3.02
Own -4%
-
Other·J
Yoshiyuki Aikawa KEY
Chairman and CEO
—
44.2K sh
-
Sell·S
Yoshiyuki Aikawa KEY
Chairman and CEO
$9.4M
4.4M sh · $2.12
Own -84%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 28, 2026 | Yoshiyuki Aikawa KEY | Sell S | 465.0K | $1.4M |
| Apr 21, 2026 | Yoshiyuki Aikawa KEY | Sell S | 3.1M | $9.4M |
| Mar 6, 2026 | Yoshiyuki Aikawa KEY | Other J | 44.2K | — |
| Mar 6, 2026 | Yoshiyuki Aikawa KEY | Sell S | 4.4M | $9.4M |
About SBC insider trading
This page tracks insider transactions for SBC Medical Group Holdings Inc (SBC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.